Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection

• Egile Nagusiak: Marta Vomero (Egilea), Cristiana Barbati (Egilea), Tania Colasanti (Egilea), Alessandra Ida Celia (Egilea), Mariangela Speziali (Egilea), Federica Maria Ucci (Egilea), Claudia Ciancarella (Egilea), Fabrizio Conti (Egilea), Cristiano Alessandri (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2020-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the novel coronavirus, causing coronavirus disease 2019 (COVID-19). During virus infection, several pro-inflammatory cytokines are produced, leading to the "cytokine storm." Among these, interleukin (IL)-6, tumor necrosis fact...